Related Experiment Video
Updated: May 31, 2026

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
MicroRNA-9 is an activation-induced regulator of PDGFR-beta expression in cardiomyocytes
Jianhu Zhang1, Vishnu Chintalgattu, Tiffany Shih
1Department of Cardiology, UT M.D. Anderson Cancer Center, USA.
Abstract:
The platelet derived growth factor receptor (PDGFR) is an important target for novel anti-cancer therapeutics, but agents targeting PDGFR have been associated with cardiotoxicity. Cardiomyocyte PDGFR-β signaling in pressure-overloaded hearts induces compensatory angiogenesis via a paracrine-signaling cascade. Tight regulation of receptor tyrosine kinases in response to ligand stimulation is a critical part of any such cascade. The objective of the present study was to characterize the early and late regulation of PDGFR-β following ligand stimulation and define a potential role for microRNAs (miRNAs) predicted to interact with the 3'UTR of PDGFR-β in feedback regulation. Using two in-vitro model systems (U87 glioblastoma cells and neonatal cardiomyocytes), we observed that in response to stimulation with PDGF-BB, levels of PDGFR-β declined beginning at one hour, persisting for 48 h. PDGFR-β mRNA levels declined beginning at 6h after receptor activation. Early, but not late activation-induced receptor downregulation was proteasome dependent. Levels of miRNA-9 (miR-9) were significantly increased in U87 cells and cardiomyocytes beginning 6h after addition of ligand. In response to pressure overload, miR-9 levels were significantly reduced in the hearts of cardiac-specific PDGFR-β knockout mice. Luciferase reporter assays demonstrate that miR-9 directly interacts with its predicted seed in the 3'UTR of PDGFR-β. Increasing miR-9 levels reduces levels of PDGFR-β, resulting in a reduction in the paracrine angiogenic capacity of cardiomyocytes, consistent with the established function of cardiomyocyte PDGFR-β. Importantly, increase of anti-miR-9 in cardiomyocytes attenuates ligand-induced PDGFR-β downregulation. In conclusion, we have identified miR-9 as an activation-induced regulator of PDGFR-β expression in cardiomyocytes that is part of a negative feedback loop which serves to modulate PDGFR-β expression upon ligand-stimulation through direct interaction with the 3'UTR of PDFGR-β. This article is part of a Special Issue entitled 'Possible Editorial'.
Insights
Platelet-derived growth factor receptor-beta (PDGFR-β) is downregulated by miRNA-9 following ligand stimulation. This negative feedback loop regulates PDGFR-β expression in cardiomyocytes, impacting angiogenesis.
Area of Science:
- Cardiovascular Biology
- Molecular Biology
- Cancer Therapeutics
Background:
- Platelet-derived growth factor receptor (PDGFR) signaling is crucial in cardiovascular adaptation and cancer, but its targeting agents cause cardiotoxicity.
- PDGFR-β in cardiomyocytes mediates angiogenesis in response to pressure overload, requiring tight regulation.
- MicroRNAs (miRNAs) are implicated in regulating receptor tyrosine kinases.
Purpose of the Study:
- To investigate the regulation of PDGFR-β following ligand stimulation.
- To identify the role of miRNAs in the feedback regulation of PDGFR-β.
- To explore the therapeutic potential of targeting PDGFR-β in cancer and cardiovascular disease.
Main Methods:
- In vitro studies using U87 glioblastoma cells and neonatal cardiomyocytes stimulated with PDGF-BB.
- Analysis of PDGFR-β and miRNA-9 (miR-9) expression levels over time.
- Proteasome activity assays.
- Cardiac-specific PDGFR-β knockout mouse model under pressure overload.
- Luciferase reporter assays to confirm miR-9 interaction with PDGFR-β 3'UTR.
Main Results:
- PDGFR-β levels decreased within 1 hour and persisted for 48 hours post-stimulation; mRNA levels declined after 6 hours.
- Early PDGFR-β downregulation was proteasome-dependent.
- miR-9 levels increased significantly in U87 cells and cardiomyocytes after 6 hours of ligand stimulation.
- miR-9 levels were reduced in hearts of PDGFR-β knockout mice under pressure overload.
- miR-9 directly interacts with the PDGFR-β 3'UTR, and its upregulation reduces PDGFR-β levels and cardiomyocyte paracrine angiogenic capacity.
- Inhibition of miR-9 attenuated ligand-induced PDGFR-β downregulation.
Conclusions:
- miR-9 acts as an activation-induced regulator of PDGFR-β expression in cardiomyocytes.
- A negative feedback loop involving miR-9 modulates PDGFR-β expression upon ligand stimulation via direct interaction with the PDGFR-β 3'UTR.
- This regulatory mechanism is critical for controlling PDGFR-β activity and its role in angiogenesis.
Related Concept Videos
MicroRNAs
MicroRNAs
Master Transcription Regulators
MAPK Signaling Cascades
